TOFACITINIB CITRATE | A215356 | AUROBINDO PHARMA LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Pfizer Inc. et al v. Aurobindo Pharma Ltd. et al 2 patentsANDA 215356tofacitinib citrate | D. Del. | 2021-01-11 | Terminated 2022-05-06 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.
Aurobindo Pharma Ltd received FDA approval for tofacitinib citrate (ANDA 215356, Supplement 002).
New: New record
Aurobindo Pharma's tofacitinib citrate product (NDA 215356) received FDA approval for marketing.
New: New record